Rubix LS

Rubix LS is announcing today veteran marketing executive, Yunche Wilson has joined the company as Chief Marketing Officer.

Rubix LS is announcing today the launch of it's new Data & Research division to its core business function.  This is a step for Rubix LS to strongly position its expertise base to move as a technological think tank.

Recognized as an Emerging Life Science Agent. Given to those who have demonstrated significant contribution to advancing unique science and engineering methodologies.

Today Rubix LS announces achievement to scale up ability to achieve manufacturing consistency of 4D printed materials.

Creating programs for high school and early college students undergoing STEM

A team from Rubix LS will tag along with a delegate from the WHO to be dispatched to Western Africa for measuring health disparities and innovation within.

Funding will be used to scale combination device development and manufacturing in anticipation of projected FDA clearance for its orthopedic combination device.

Rubix LS creating footprints in more areas….now in Washington DC

Taking new initiatives in development of proactive devices that can stem the rising tide of opioid addiction.

Rubix LS is pleased to announce major strides in the development of an advanced treatment discovery platform.